OREXIGEN THERAPEUTICS INC's ticker is OREXXXXX and the CUSIP is 686164104. A total of 136 filers reported holding OREXIGEN THERAPEUTICS INC in Q3 2015. The put-call ratio across all filers is 0.53 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $709,000 | -72.3% | 413,200 | -66.0% | 0.38% | -68.0% |
| Q3 2015 | $2,558,000 | -65.1% | 1,215,392 | -18.1% | 1.20% | -49.5% |
| Q2 2015 | $7,339,000 | -36.7% | 1,484,045 | -0.0% | 2.37% | -15.1% |
| Q1 2015 | $11,601,000 | +80.7% | 1,484,409 | +40.2% | 2.80% | +65.7% |
| Q4 2014 | $6,421,000 | +117.1% | 1,058,656 | +52.6% | 1.69% | +60.2% |
| Q3 2014 | $2,958,000 | – | 693,642 | – | 1.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management III, LLC | 3,000,000 | $5,160,000 | 4.58% |
| Foresite Capital Management II, LLC | 6,225,049 | $10,707,000 | 3.59% |
| Scale Management, LLC | 1,312,575 | $2,258,000 | 3.46% |
| NEA Management Company, LLC | 3,709,000 | $6,379,000 | 0.41% |
| Cheyne Capital Management (UK) LLP | 413,200 | $709,000 | 0.38% |
| Rhenman & Partners Asset Management AB | 1,189,000 | $2,045,000 | 0.31% |
| SAMLYN CAPITAL, LLC | 6,160,417 | $10,596,000 | 0.22% |
| Rock Springs Capital Management LP | 1,650,000 | $2,838,000 | 0.22% |
| Palo Alto Investors LP | 1,673,024 | $2,878,000 | 0.16% |
| GLOBEFLEX CAPITAL L P | 295,000 | $507,000 | 0.14% |